Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 6/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10020148 | 0.88 | HCRTR1 (0.32) | HCRTR1HCRTR2 | |
| SCHEMBL19622010 | 0.87 | HCRTR1 (0.33) | HCRTR1HCRTR2 | |
| SCHEMBL10020163 | 0.87 | L3MBTL1 (0.40) | HCRTR1HCRTR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10020150 | 0.84 | HCRTR1 (0.32) | HCRTR1HCRTR2GABRA1GABRB2CYP1A2 | |
| SCHEMBL15257993 | 0.84 | HCRTR1 (0.38) | HCRTR1HCRTR2 | |
| SCHEMBL10020093 | 0.84 | HCRTR1 (0.35) | HCRTR1HCRTR2GABRA1GABRB2 | |
| SCHEMBL10019938 | 0.84 | KDM1A (0.35) | GABRA1GABRB2FFAR4CYP2C9CYP2C19 | |
| SCHEMBL10020152 | 0.83 | KDM1A (0.38) | HCRTR1HCRTR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10019989 | 0.83 | FFAR4 (0.39) | GABRA1GABRB2FFAR4 | |
| SCHEMBL10020144 | 0.82 | FAAH (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669263-B1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| WO-2012086437-A1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | JNC株式会社 (JP) | 2012-06-28 | — | — | WO | disclosed |